$112.23 -0.54 (%) Johnson & Johnson - New York Stock Exchange, Inc.

Apr. 28, 2016 | 03:50 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Everything You Might Have Missed This 13F Season: Part 2

    Benzinga | Feb. 17, 2016 | 15:58PM EST
  2. What To Do When The Stock Market Falls

    GuruFocus | Feb. 16, 2016 | 11:03AM EST
  3. The Stocks That Moved The S&P, Dow And Nasdaq Yesterday

    Benzinga | Feb. 13, 2016 | 22:44PM EST
  4. Tweedy Browne Trims Stakes in Financial Stocks

    GuruFocus | Feb. 12, 2016 | 17:32PM EST
  5. Intercept Pharma Spikes On Report That It’s Exploring A Sale

    IBD | Feb. 12, 2016 | 15:30PM EST
  6. Gilead, Johnson & Johnson or Roche?

    GuruFocus | Feb. 11, 2016 | 12:15PM EST
  7. Icahn, Gilead, GE Lead Top Insider Trades Of The Week

    Benzinga | Feb. 9, 2016 | 16:07PM EST
  8. Stocks To Buy For A Recession — And For A Recovery

    IBD | Feb. 9, 2016 | 13:46PM EST
  9. How To Invest In An Aging World With The 'Live Long & Prosper' ETF

    Benzinga | Feb. 8, 2016 | 10:53AM EST
  10. S&P 500 Index Futures Sharply Lower

    Benzinga | Feb. 8, 2016 | 10:27AM EST
  11. Consider This Market With Negligible Volatility and Consistently Rising Values

    GuruFocus | Feb. 5, 2016 | 15:23PM EST
  12. Valeant's Share Price Continues to Decline

    GuruFocus | Feb. 5, 2016 | 15:10PM EST
  13. Another Stock Market Meltdown; Nike Leads Dow Down 200 Points

    IBD | Feb. 5, 2016 | 11:55AM EST
  14. Techs Tumble in Early Trade; Tyson Foods Wings Higher

    IBD | Feb. 5, 2016 | 10:53AM EST
  15. How To Build A Defensive Portfolio

    Benzinga | Feb. 4, 2016 | 15:13PM EST
  16. How To Build A Defensive Portfolio

    Benzinga | Feb. 4, 2016 | 15:13PM EST
  17. Intuitive Surgical Making A Comeback As Robotic Surgery Gains Ground

    IBD | Feb. 3, 2016 | 16:02PM EST
  18. Benzinga's M&A Chatter for Thursday January 28, 2015

    Benzinga | Jan. 28, 2016 | 23:27PM EST
  19. UPDATE: Artisan Partners Global Value's Daniel O'Keefe Sends Letter to J&J Board

    Benzinga | Jan. 28, 2016 | 09:53AM EST
  20. Johnson & Johnson: Dividend Aristocrats Part 50

    GuruFocus | Jan. 27, 2016 | 11:50AM EST
  21. Johnson & Johnson Continues To Rally

    Benzinga | Jan. 27, 2016 | 10:41AM EST
  22. S&P 500 Index Futures Lower

    Benzinga | Jan. 27, 2016 | 10:16AM EST
  23. Earnings Recap For January 26

    Benzinga | Jan. 26, 2016 | 17:15PM EST
  24. S&P 500 Index Futures Sharply Higher

    Benzinga | Jan. 26, 2016 | 13:57PM EST
  25. No Shortage of Stock Drivers: Oil Swivels, Fed Meets, Apple Reports

    Benzinga | Jan. 26, 2016 | 10:59AM EST
  26. JNJ Kicks Off Health Care Earnings—What About Deals, Buybacks?

    Benzinga | Jan. 25, 2016 | 11:43AM EST
  27. Big Data Marries Tech, Health

    IBD | Jan. 21, 2016 | 18:42PM EST
  28. Alphabet, Apple In Tech Health Care 'Convergence'

    IBD | Jan. 21, 2016 | 08:02AM EST
  29. Johnson & Johnson

    IBD | Jan. 19, 2016 | 18:48PM EST
  30. J&J restructuring, cutting jobs

    IBD | Jan. 19, 2016 | 18:48PM EST
  31. Najarian Brothers See Unusual Activity In Johnson & Johnson And Cisco Systems, Inc.

    Benzinga | Jan. 19, 2016 | 15:23PM EST
  32. J&J Overhauling Device Business, Cutting 3,000 Jobs

    IBD | Jan. 19, 2016 | 13:32PM EST
  33. Johnson & Johnson Restructures Medical Devices Unit, Sees Nearly $1 Billion In Annual Cost Savings

    Benzinga | Jan. 19, 2016 | 13:04PM EST
  34. Stocks Up, Opening Surge Eases; NetEase, Tal Education Top IBD 50

    IBD | Jan. 19, 2016 | 10:39AM EST
  35. Three Stock Picks for 2016

    GuruFocus | Jan. 15, 2016 | 11:08AM EST
  36. Investment Ideas Trading With Very Low P/S Ratio

    GuruFocus | Jan. 13, 2016 | 17:44PM EST
  37. How Invasive Will Google Be To Intuitive's Da Vinci?

    IBD | Jan. 5, 2016 | 12:35PM EST
  38. Cyborgs, M&A, iPhone 7: Trends Topping 2016 Chips

    IBD | Jan. 4, 2016 | 08:02AM EST
  39. Why Dividend Growth Investing Should Be Your New Year's Resolution

    GuruFocus | Jan. 3, 2016 | 11:07AM EST
  40. Dividend Aristocrats Part 39: Kimberly-Clark

    GuruFocus | Dec. 30, 2015 | 11:47AM EST
  41. 5 Guru Picks in Volatile Biotech Industry

    GuruFocus | Dec. 23, 2015 | 14:24PM EST
  42. Microsoft, Intel, Alphabet Lead Field In R&D Spending

    IBD | Dec. 23, 2015 | 08:02AM EST
  43. Medivir Announces Development of AL-704 Terminated by Janssen Following Completion of Phase I Clinical Studies

    Benzinga | Dec. 21, 2015 | 04:17AM EST
  44. Analyzing Amgen's Dividend Hike

    GuruFocus | Dec. 21, 2015 | 00:03AM EST
  45. Stock Futures' Early Losses Ease; CarMax Misfires, Red Hat Thrives

    IBD | Dec. 18, 2015 | 08:59AM EST
  46. 4 Top Dividend Plays To Help Cure Stock Price Blues

    IBD | Dec. 17, 2015 | 17:14PM EST
  47. Ahead of the Fed: Energy, Financials Energize Stocks

    FoxBusiness | Dec. 15, 2015 | 16:00PM EST
  48. Mairs and Power Buys American Express, Pfizer in 3rd Quarter

    GuruFocus | Dec. 10, 2015 | 17:01PM EST
  49. Google, J&J Robotics Move Targets Intuitive Surgical

    IBD | Dec. 10, 2015 | 09:53AM EST
  50. S&P 500 Index Futures Under Pressure

    Benzinga | Dec. 7, 2015 | 11:24AM EST
Trading Center